[go: up one dir, main page]

FI912933L - Radiofarmaceutiska kompositioner, foerfarande foer administrering av dessa samt foerfarande foer framstaellning av dessa. - Google Patents

Radiofarmaceutiska kompositioner, foerfarande foer administrering av dessa samt foerfarande foer framstaellning av dessa. Download PDF

Info

Publication number
FI912933L
FI912933L FI912933A FI912933A FI912933L FI 912933 L FI912933 L FI 912933L FI 912933 A FI912933 A FI 912933A FI 912933 A FI912933 A FI 912933A FI 912933 L FI912933 L FI 912933L
Authority
FI
Finland
Prior art keywords
dessa
foerfarande foer
radiopharmaceutiska
kompositioner
administrating
Prior art date
Application number
FI912933A
Other languages
English (en)
Other versions
FI912933A0 (fi
FI101044B (fi
Inventor
Jaime Simon
Joseph R Garlich
R Keith Frank
Kenneth Mcmillan
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of FI912933A0 publication Critical patent/FI912933A0/fi
Publication of FI912933L publication Critical patent/FI912933L/fi
Application granted granted Critical
Publication of FI101044B publication Critical patent/FI101044B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
FI912933A 1990-06-18 1991-06-17 Menetelmä radiofarmaseuttisen koostumuksen valmistamiseksi, joka käsit tää radionuklidin ja ligandin muodostaman kompleksin FI101044B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53887190A 1990-06-18 1990-06-18

Publications (3)

Publication Number Publication Date
FI912933A0 FI912933A0 (fi) 1991-06-17
FI912933L true FI912933L (fi) 1991-12-19
FI101044B FI101044B (fi) 1998-04-15

Family

ID=24148781

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912933A FI101044B (fi) 1990-06-18 1991-06-17 Menetelmä radiofarmaseuttisen koostumuksen valmistamiseksi, joka käsit tää radionuklidin ja ligandin muodostaman kompleksin

Country Status (32)

Country Link
US (1) US5762907A (fi)
EP (1) EP0462787B1 (fi)
JP (2) JP3636728B2 (fi)
KR (1) KR100219964B1 (fi)
CN (1) CN1033143C (fi)
AT (1) ATE123955T1 (fi)
AU (2) AU651112B2 (fi)
BR (2) BR9102579A (fi)
CA (1) CA2044812C (fi)
CS (1) CS184291A3 (fi)
CY (1) CY1891A (fi)
DE (1) DE69110554T2 (fi)
DK (1) DK0462787T3 (fi)
EG (1) EG19862A (fi)
ES (1) ES2073678T3 (fi)
FI (1) FI101044B (fi)
GR (1) GR3017430T3 (fi)
HK (1) HK80496A (fi)
HU (1) HU226897B1 (fi)
IE (1) IE71023B1 (fi)
IL (1) IL98536A (fi)
IS (1) IS1704B (fi)
MC (1) MC2260A1 (fi)
NO (1) NO302510B1 (fi)
NZ (1) NZ238547A (fi)
PH (1) PH30975A (fi)
PL (1) PL165699B1 (fi)
PT (1) PT97996B (fi)
RU (1) RU2095085C1 (fi)
SA (1) SA92120343B1 (fi)
SK (1) SK279598B6 (fi)
ZA (1) ZA914615B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410043A (en) * 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
US5405601A (en) * 1993-07-02 1995-04-11 Mallinckrodt Medical Inc. Functionalized tripodal ligands for imaging applications
CN1065769C (zh) * 1997-07-03 2001-05-16 中国原子能科学研究院 一种放射性药物制剂的制备方法
CN1092962C (zh) * 1998-01-26 2002-10-23 贾伟 一种减轻骨及骨关节疾病疼痛的药物
RU2164420C2 (ru) * 1999-02-10 2001-03-27 Государственный научный центр Российской Федерации Физико-энергетический институт им. акад. А.И. Лейпунского Способ получения радиотерапевтического препарата
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
RU2162714C1 (ru) * 2000-06-20 2001-02-10 Государственный научный центр РФ - Институт биофизики Радиофармацевтическая композиция
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
RU2205030C2 (ru) * 2001-02-13 2003-05-27 Осминин Александр Георгиевич Средство для рентгенологического исследования
RU2182022C1 (ru) * 2001-05-24 2002-05-10 Российская медицинская академия последипломного образования МЗ РФ Способ лечения онкологических заболеваний щитовидной железы
RU2191033C1 (ru) * 2001-05-24 2002-10-20 Юминов Олег Аркадьевич Радиофармацевтический препарат "астат-211" для лечения онкологических заболеваний щитовидной железы
US6567492B2 (en) 2001-06-11 2003-05-20 Eastern Isotopes, Inc. Process and apparatus for production of F-18 fluoride
KR101001300B1 (ko) 2002-11-05 2010-12-14 이온빔 어플리케이션스 에스.에이. 18-에프로 표지된 방사선 약물들의 안정화
US7018614B2 (en) * 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
RU2297247C2 (ru) * 2005-06-20 2007-04-20 Государственное учреждение "Институт химии твердого тела" Уральского отделения Российской академии наук Средство для контрастирования при рентгенодиагностике (варианты)
MX362001B (es) 2013-05-13 2019-01-03 Vision Global Holdings Ltd Composición farmacéutica que comprende un agente terapéutico a base de hemoglobina modificada para tratamiento dirigido al cáncer e imagenología diagnóstica.
FI3054996T3 (fi) * 2013-10-07 2023-08-31 Igl Pharma Inc Menetelmä erittäin puhtaiden terapeuttisten luulääkeaineiden valmistamiseksi
KR102668112B1 (ko) 2014-12-04 2024-05-23 지이 헬쓰케어 리미티드 방사성 약제로부터의 아세트알데히드의 제거 방법
RU2593017C1 (ru) * 2015-04-23 2016-07-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения радиофармацевтического препарата "астат-211"
WO2016187514A1 (en) * 2015-05-21 2016-11-24 Actinium Pharmaceueuticals, Inc. Infusion administration of conjugated monoclonal antibodies
US11369700B2 (en) * 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
US20180104366A1 (en) * 2015-05-25 2018-04-19 Isotherapeutics Group, Llc Dotmp kit formulations for radioisotopes
RU2757258C1 (ru) * 2020-09-28 2021-10-12 федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский ядерный университет "МИФИ" (НИЯУ МИФИ) Способ получения радиофармацевтического препарата с галлием-68 для визуализации метастазов скелета методом пэт

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018883A (en) * 1975-03-10 1977-04-19 Nichols Institute For Endocrinology Thyroxine (T4) radioimmunoassay
NL7605447A (nl) * 1975-06-26 1976-12-28 Byk Mallinckrodt Chem Prod Radioimmunoproefmethode voor de bepaling van thyroxine.
US4301140A (en) * 1979-12-14 1981-11-17 G. D. Searle & Co. Radiopharmaceutical method for monitoring kidneys
US4341755A (en) * 1980-07-15 1982-07-27 Immuno Nuclear Corporation Parathyroid radioimmunoassay
US4457602A (en) * 1981-04-20 1984-07-03 Olympus Optical Company Ltd. Multiple light emission control system utilizing electronic flashes
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
DE164843T1 (de) * 1984-06-04 1989-12-07 The Dow Chemical Co., Midland, Mich. Organische aminphosphonsaeurekomplexe fuer die behandlung von verkalkenden tumoren.
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4752464A (en) * 1985-06-07 1988-06-21 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
NZ222304A (en) * 1987-05-18 1990-10-26 Dow Chemical Co Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
ATE130518T1 (de) * 1987-06-30 1995-12-15 Mallinckrodt Inc Verfahren zur erhöhung der sicherheit von metall- ligandchelaten als röntgenstrahlen- kontrastmittel.
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4937333A (en) * 1989-08-04 1990-06-26 The Dow Chemical Company Method for purifying aminomethylenephosphonic acids for pharmaceutical use
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes

Also Published As

Publication number Publication date
IE71023B1 (en) 1997-01-15
IL98536A0 (en) 1992-07-15
EG19862A (en) 1996-06-30
DE69110554T2 (de) 1995-12-14
ZA914615B (en) 1993-02-24
IS3717A7 (is) 1991-12-19
PH30975A (en) 1997-12-23
HU226897B1 (en) 2010-01-28
NO912345L (no) 1991-12-19
CA2044812A1 (en) 1991-12-19
CN1063615A (zh) 1992-08-19
KR100219964B1 (ko) 1999-09-01
CY1891A (en) 1996-08-30
JPH04230224A (ja) 1992-08-19
CN1033143C (zh) 1996-10-30
CS184291A3 (en) 1992-02-19
AU7847091A (en) 1991-12-19
PT97996A (pt) 1992-03-31
AU651112B2 (en) 1994-07-14
BR9102579A (pt) 1992-01-21
DE69110554D1 (de) 1995-07-27
PL290717A1 (en) 1992-02-24
HUT57994A (en) 1992-01-28
JP3636728B2 (ja) 2005-04-06
PT97996B (pt) 1998-11-30
FI912933A0 (fi) 1991-06-17
HK80496A (en) 1996-05-17
KR920000334A (ko) 1992-01-29
NO302510B1 (no) 1998-03-16
US5762907A (en) 1998-06-09
EP0462787A1 (en) 1991-12-27
JP2002114712A (ja) 2002-04-16
BR1101169A (pt) 2000-08-08
NO912345D0 (no) 1991-06-17
IS1704B (is) 1998-12-10
DK0462787T3 (da) 1995-10-30
AU6455994A (en) 1994-08-04
SA92120343B1 (ar) 2004-01-25
EP0462787B1 (en) 1995-06-21
HU912011D0 (en) 1991-12-30
GR3017430T3 (en) 1995-12-31
AU665911B2 (en) 1996-01-18
PL165699B1 (pl) 1995-01-31
CA2044812C (en) 2002-12-31
IL98536A (en) 1996-10-31
RU2095085C1 (ru) 1997-11-10
MC2260A1 (fr) 1993-04-26
SK279598B6 (sk) 1999-01-11
NZ238547A (en) 1994-05-26
ES2073678T3 (es) 1995-08-16
ATE123955T1 (de) 1995-07-15
FI101044B (fi) 1998-04-15
IE912057A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
FI912933L (fi) Radiofarmaceutiska kompositioner, foerfarande foer administrering av dessa samt foerfarande foer framstaellning av dessa.
FI923721A0 (fi) Oeppna kapillaerkanalstrukturer, foerfarande foer framstaellning av kapillaerkanalstrukturer samt vid foerfarandet anvaend extrusionsform.
FI914766L (fi) Klorfri traemassa samt foerfarande foer framstaellning av denna.
FI906469A0 (fi) Foerfarande foer diagnosticering av spraengning av fosterhinnor samt reagensfoerpackning foer anvaendning daervid.
FI912381A7 (fi) Foerfarande foer delvis elektrolytisk dehalogenering av di- och trikloraettikssyra samt elektrolysloesning.
FI923513A0 (fi) Foerfarande foer framstaellning av en cellkonstruktion, anordning foer utfoerande av metoden, samt cellkonstruktionens anvaendning foer kontinuerlig tillverkning av en foerbindningsplatta.
FI910170A7 (fi) Foerankrings- och moringssystem av plattformer samt foerankringsenhet.
FI913317A0 (fi) Foerfarande foer framstaellning av trae-plast-agglomerat, samt anvaendning daerav.
FI901184L (fi) Vaddmatta samt foerfarande foer tillverkning av densamma.
FI915245A7 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
FI891110L (fi) Foerfarande foer framstaellning av finfiber, samt finfiber.
FI911590A0 (fi) Oxidisk superledande traod, foerfarande foer framstaellning av samma samt foerfarande foer behandling av samma.
FI912872A0 (fi) Kristall av fluoranblandning, foerfarande foer framstaellning av naemnda kristall samt registreringsmaterial omfattande naemnda kristall.
FI923890A0 (fi) Aongstraole- och vakuumanordning samt foerfarande foer anvaendning av densamma.
FI923763A0 (fi) Inklaednad av bergvaeggar saosom tunnlar och dylikt, samt saett foer att aostadkomma inklaednaden.
FI900591A7 (fi) Apparatenhet foer fartyg, foerfarande foer apparatmontage samt formmedel foer tillverkning av flaensorgan.
FI902682A0 (fi) Foerfarande foer luftkonditionering av en byggnad samt en luftkonditionerad byggnad.
FI87006B (fi) Foerfarande foer installering av en bergbult samt en bergbult.
FI913774L (fi) Syraadditionssalter av optiskt aktiva alaninanilidfoereningar samt farmaceutiska kompositioner innehaollande dessa.
FI902595L (fi) Foerfarande foer styrning av en elektronstraole i en elektronaccelerator samt en elektronaccelerator.
FI902260A0 (fi) Foerfarande foer avlaegsnande av svavelfoereningar fraon roekgas samt en reaktor foer tillaempning av foerfarandet.
FI905015A0 (fi) Krossningsanordning foer engaongsinjektionsnaolar, sprutor, ampuller, skaerknivar samt mindre operationsredskap.
FI904702L (fi) Gift foer skadedjur, i synnerhet foer gnagare, samt foerfarande foer framstaellning av giftet.
FI901365A7 (fi) Anordning foer stabilisering av fartyg samt foerfarande foer stabilisering av fartyg.
FI900638L (fi) Foerfarande foer avkylning av en elektrisk komponent samt en avkylare framstaelld enligt foerfarandet.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE DOW CHEMICAL COMPANY

PC Transfer of assignment of patent

Owner name: DR. REDDY S LABORATORIES (EU) LIMITED

Free format text: DR. REDDY S LABORATORIES (EU) LIMITED

MA Patent expired